Acadia Pharmaceuticals ACAD Short Term Inventory
Short Term Inventory at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept acad:ShortTermInventory.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's short term inventory.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's short term inventory?
- Acadia Pharmaceuticals (ACAD) reported short term inventory of $31.57M in Q1 2026.
- How has Acadia Pharmaceuticals's short term inventory changed year-over-year?
- Acadia Pharmaceuticals's short term inventory increased by 37.6% year-over-year, from $22.95M to $31.57M.
- What is the long-term trend for Acadia Pharmaceuticals's short term inventory?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's short term inventory has grown at a 29.1% compound annual growth rate (CAGR), from $9.68M to $34.67M.
- What does short term inventory mean?
- This metric represents inventory items that are classified as non-current assets, typically due to long-term aging, strategic stockpiling, or specific regulatory holding requirements that extend beyond the standard operating cycle. It captures the value of goods held for commercialization or internal use that are not expected to be sold or converted into cash within the next twelve months. Tracking this balance is essential for assessing capital tied up in long-dated product supply chains and potential obsolescence risk.